Annals of the New York Academy of Sciences · 2002
Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cutolo M, Sulli A, Pizzorni C, Craviotto C, Prete C, Foppiani L, Salvarani C, Straub R H, Seriolo B
Аннотация
This paper aims to evaluate adrenal gland hormone levels in patients with polymyalgia rheumatica (PMR) during glucocorticoid (GC) therapy. A lower than expected basal production of cortisol was found in active and glucocorticoid-untreated PMR patients, particularly females. The abrupt onset of PMR with clinical features similar to those of the steroid-withdrawal syndrome or adrenal insufficiency, as well as the clinical response to GC therapy in elderly people already age-disposed to an inadequate adrenal and anti-inflammatory response, might represent the most significant pathophysiological basis of the disease.
Предметные рубрики MeSH
Adrenal CortexAdrenal Hyperplasia, CongenitalAdrenocorticotropic HormoneAgedAgingAndrostenedioneArea Under CurveBiomarkersBlood SedimentationC-Reactive ProteinCorticotropin-Releasing HormoneDehydroepiandrosteroneFemaleHumansHydrocortisoneHypothalamo-Hypophyseal SystemInflammationInterleukin-6MaleNeuroimmunomodulationPituitary-Adrenal SystemPolymyalgia RheumaticaSecretory RateTestis